SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $312,065 | -82.8% | 11,319 | -81.3% | 0.00% | -83.3% |
| Q2 2023 | $1,817,488 | +26.8% | 60,462 | +52.8% | 0.01% | +20.0% |
| Q1 2023 | $1,433,331 | -1.4% | 39,562 | -3.0% | 0.01% | 0.0% |
| Q4 2022 | $1,454,087 | +410.2% | 40,765 | +274.0% | 0.01% | +400.0% |
| Q1 2021 | $285,000 | -94.4% | 10,900 | -94.6% | 0.00% | -95.5% |
| Q4 2020 | $5,096,000 | -3.5% | 202,528 | -20.1% | 0.02% | +4.8% |
| Q3 2020 | $5,279,000 | +17.8% | 253,328 | +34.3% | 0.02% | -8.7% |
| Q2 2020 | $4,481,000 | +97.6% | 188,673 | +49.6% | 0.02% | +53.3% |
| Q1 2020 | $2,268,000 | -18.3% | 126,091 | +7.8% | 0.02% | +66.7% |
| Q4 2019 | $2,775,000 | +77.8% | 117,016 | +106.0% | 0.01% | +50.0% |
| Q3 2019 | $1,561,000 | +16.8% | 56,791 | +40.6% | 0.01% | +20.0% |
| Q2 2019 | $1,336,000 | -72.3% | 40,380 | -70.6% | 0.01% | -72.2% |
| Q1 2019 | $4,817,000 | +2182.9% | 137,457 | +2065.4% | 0.02% | +1700.0% |
| Q4 2018 | $211,000 | -96.3% | 6,348 | -94.4% | 0.00% | -95.2% |
| Q3 2018 | $5,740,000 | -43.0% | 114,010 | -32.2% | 0.02% | -48.8% |
| Q2 2018 | $10,063,000 | -5.8% | 168,152 | -27.9% | 0.04% | -16.3% |
| Q1 2018 | $10,681,000 | – | 233,214 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 42,189 | $1,220,950 | 0.03% |
| MASSMUTUAL TRUST CO FSB/ADV | 320 | $9,261 | 0.00% |
| Versant Capital Management, Inc | 16 | $463 | 0.00% |